BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Droctové L, Lancien M, Tran VL, et al. (2020) A snake toxin as a theranostic agent for the type 2 vasopressin receptor. Theranostics. 10: 11580-11594
Mendre C, Mouillac B. (2019) Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics. Advances in Protein Chemistry and Structural Biology. 118: 249-272
Perkovska S, Méjean C, Ayoub MA, et al. (2017) V1b vasopressin receptor trafficking and signaling : role of arrestins, G proteins and Src kinase. Traffic (Copenhagen, Denmark)
Mouillac B, Mendre C. (2017) Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors. Handbook of Experimental Pharmacology
Ciolek J, Reinfrank H, Quinton L, et al. (2017) Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America
Karpenko IA, Kreder R, Valencia C, et al. (2014) Red fluorescent turn-on ligands for imaging and quantifying G protein-coupled receptors in living cells. Chembiochem : a European Journal of Chemical Biology. 15: 359-63
Mouillac B, Mendre C. (2014) Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies. Pharmacological Research. 83: 74-8
Rahmeh R, Damian M, Cottet M, et al. (2012) Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proceedings of the National Academy of Sciences of the United States of America. 109: 6733-8
Bellot G, Pascal R, Mendre C, et al. (2011) Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor Protein Expression and Purification. 78: 131-138
Mendre C, Mouillac B. (2010) [Pharmacological chaperones: a potential therapeutic treatment for conformational diseases]. Medecine Sciences : M/S. 26: 627-35
See more...